These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cortical layer-dependent BOLD and CBV responses measured by spin-echo and gradient-echo fMRI: insights into hemodynamic regulation. Zhao F; Wang P; Hendrich K; Ugurbil K; Kim SG Neuroimage; 2006 May; 30(4):1149-60. PubMed ID: 16414284 [TBL] [Abstract][Full Text] [Related]
3. Comparison of gradient- and spin-echo imaging: CBF, CBV, and MTT measurements by bolus tracking. Simonsen CZ; Ostergaard L; Smith DF; Vestergaard-Poulsen P; Gyldensted C J Magn Reson Imaging; 2000 Sep; 12(3):411-6. PubMed ID: 10992308 [TBL] [Abstract][Full Text] [Related]
4. High-resolution CMR(O2) mapping in rat cortex: a multiparametric approach to calibration of BOLD image contrast at 7 Tesla. Kida I; Kennan RP; Rothman DL; Behar KL; Hyder F J Cereb Blood Flow Metab; 2000 May; 20(5):847-60. PubMed ID: 10826536 [TBL] [Abstract][Full Text] [Related]
5. An integrative model for neuronal activity-induced signal changes for gradient and spin echo functional imaging. Uludağ K; Müller-Bierl B; Uğurbil K Neuroimage; 2009 Oct; 48(1):150-65. PubMed ID: 19481163 [TBL] [Abstract][Full Text] [Related]
7. Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T. Mandeville JB; Jenkins BG; Chen YC; Choi JK; Kim YR; Belen D; Liu C; Kosofsky BE; Marota JJ Magn Reson Med; 2004 Dec; 52(6):1272-81. PubMed ID: 15562489 [TBL] [Abstract][Full Text] [Related]
8. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imaging: a simplified T1-weighted steady-state cerebral blood volume approach. Wirestam R; Knutsson L; Risberg J; Börjesson S; Larsson EM; Gustafson L; Passant U; Ståhlberg F Acta Radiol; 2007 Jun; 48(5):550-6. PubMed ID: 17520432 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the morphological and functional effects of the anti-angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI. Quarles CC; Schmainda KM Magn Reson Med; 2007 Apr; 57(4):680-7. PubMed ID: 17390352 [TBL] [Abstract][Full Text] [Related]
10. Arterial versus total blood volume changes during neural activity-induced cerebral blood flow change: implication for BOLD fMRI. Kim T; Hendrich KS; Masamoto K; Kim SG J Cereb Blood Flow Metab; 2007 Jun; 27(6):1235-47. PubMed ID: 17180136 [TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension. Zaharchuk G; Mandeville JB; Bogdanov AA; Weissleder R; Rosen BR; Marota JJ Stroke; 1999 Oct; 30(10):2197-204; discussion 2204-5. PubMed ID: 10512929 [TBL] [Abstract][Full Text] [Related]
12. Functional and morphological effects of diazepam and midazolam on tumor vasculature in the 9L gliosarcoma brain tumor model using dynamic susceptibility contrast MRI: a comparative study. Yan N; Zheng Y; Yang C Drug Des Devel Ther; 2017; 11():2931-2936. PubMed ID: 29042753 [TBL] [Abstract][Full Text] [Related]
13. Sources of phase changes in BOLD and CBV-weighted fMRI. Zhao F; Jin T; Wang P; Hu X; Kim SG Magn Reson Med; 2007 Mar; 57(3):520-7. PubMed ID: 17326174 [TBL] [Abstract][Full Text] [Related]
14. Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2* MRI. Newman GC; Hospod FE; Patlak CS; Fain SE; Pulfer KA; Cook TD; O'Sullivan F J Cereb Blood Flow Metab; 2006 Jun; 26(6):760-70. PubMed ID: 16319833 [TBL] [Abstract][Full Text] [Related]
15. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI. Wong AM; Yan FX; Liu HL J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620 [TBL] [Abstract][Full Text] [Related]
16. In vivo determination of absolute cerebral blood volume using hemoglobin as a natural contrast agent: an MRI study using altered arterial carbon dioxide tension. Ulatowski JA; Oja JM; Suarez JI; Kauppinen RA; Traystman RJ; van Zijl PC J Cereb Blood Flow Metab; 1999 Jul; 19(7):809-17. PubMed ID: 10413037 [TBL] [Abstract][Full Text] [Related]
17. Monitoring angiogenesis in brain using steady-state quantification of DeltaR2 with MION infusion. Dunn JF; Roche MA; Springett R; Abajian M; Merlis J; Daghlian CP; Lu SY; Makki M Magn Reson Med; 2004 Jan; 51(1):55-61. PubMed ID: 14705045 [TBL] [Abstract][Full Text] [Related]
18. Endogenous functional CBV contrast revealed by diffusion weighting. Harshbarger TB; Song AW NMR Biomed; 2006 Dec; 19(8):1020-7. PubMed ID: 16894639 [TBL] [Abstract][Full Text] [Related]
19. Cortical depth-dependent gradient-echo and spin-echo BOLD fMRI at 9.4T. Zhao F; Wang P; Kim SG Magn Reson Med; 2004 Mar; 51(3):518-24. PubMed ID: 15004793 [TBL] [Abstract][Full Text] [Related]
20. Robust MR assessment of cerebral blood volume and mean vessel size using SPION-enhanced ultrashort echo acquisition. Han SH; Cho JH; Jung HS; Suh JY; Kim JK; Kim YR; Cho G; Cho H Neuroimage; 2015 May; 112():382-389. PubMed ID: 25818683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]